Market Trends– category –
-
All G Unveils Bovine-Free Lactoferrin in U.S. via Precision Fermentation, Establishing Multi-Ton Annual Production Capacity
foodnavigator-usa.com USA Overview All G has announced the launch of bovine-free lactoferrin in the U.S. market, produced using precision fermentation technology, with human-identical protein launch imminent. The company has partnered wi... -
Fujifilm Prepares for Patent Cliff with Strategic CDMO Investments; Samsung Biologics Acquires PolyPeptide for $1.8B, Entering Peptide Market
Endpoints News Global Overview The pharmaceutical industry faces a 'patent cliff' with ~$300 billion in branded drug revenues at risk from 2025-2030, driving active deals for portfolio expansion and cost efficiency. Contract Development ... -
Repligen Acquires BioLife Solutions for ~$1.5B, Expanding Cell Therapy Services; Beone Medicines Invests $300M in US Manufacturing Expansion
Endpoints News USA Overview Repligen has announced the acquisition of cell processing service provider BioLife Solutions for approximately $1.5 billion, significantly broadening its capabilities within the cell therapy sector. Concurrent... -
Precision Fermentation Drives Next-Gen Food Innovation: MycoTechnology Unveils Honey Truffle Sweet Protein, All G Launches Cow-Free Lactoferrin in US
foodingredientsfirst.com / Precision Fermentation News / flavorist.com / Vivici / Microbio International Overview Precision fermentation is significantly advancing the next-generation food ingredient market. MycoTechnology announced its ... -
Cultivated Meat Regulation Matures Globally: US Federal Approvals, ANZ Standards, and UK Guidance Set New Benchmarks
Dr. Mercola International Overview The global regulatory environment for cultivated meat is rapidly advancing, with five products completing federal review in the US, alongside new cell-cultivated food standards in Australia/New Zealand ... -
AGC Biologics Secures Landmark Multi-Hundred-Million-Dollar Deal for Yokohama Facility, Cementing Japan’s Biologics Manufacturing Leadership
AGC Biologics Japan Overview AGC Biologics has secured a multi-year, multi-hundred-million-dollar commercial manufacturing agreement for its new Yokohama facility, slated to open in 2027. This landmark deal dedicates approximately half o... -
Reusable Bioreactor Market Surges: Driven by Large-Volume Biologics Production and CDMO Capacity Expansion, Hybrid Manufacturing Emerges
Constancy Researchers USA Overview The reusable bioreactor market is experiencing substantial growth, propelled by the increasing demand for large-volume commercial biopharmaceutical production and the expansion of CDMO capacities. A not... -
Perfusion Bioreactor Market Surges Driven by Continuous Biomanufacturing and Intensified Bioprocessing; Thermo Fisher’s DynaDrive Platform Leads
Constancy Researchers USA Overview The perfusion bioreactor market is experiencing rapid growth, primarily fueled by the adoption of continuous biomanufacturing and intensified bioprocessing strategies. Thermo Fisher Scientific's HyPerfo... -
Thermo Fisher Unveils DynaDrive 5L Single-Use Bioreactor, Enabling Seamless 1L to 5,000L Scale-Up for Biologics Manufacturing
Constancy Researchers USA Overview Thermo Fisher Scientific has launched its DynaDrive 5L single-use bioreactor, designed to enhance workflow efficiency in biopharmaceutical manufacturing. This new system facilitates seamless culture sca... -
European Hydrogen Observatory Updates Datasets, Revealing Latest Figures for 2025 Hydrogen FCEVs, May 2026 Refueling Stations, and Electrolyzer Manufacturing Capacity
European Hydrogen Observatory Europe Overview The European Hydrogen Observatory has released updated datasets, including figures for 2025 hydrogen Fuel Cell Electric Vehicles (FCEVs), the status of operational hydrogen refueling stations...
